Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA

Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA–MORAb-003

Published:2008-04 Issue:3 Volume:35 Page:343-351
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Smith-Jones Peter M.,Pandit-Taskar Neeta,Cao Wei,O'Donoghue Joseph,Philips Martin D.,Carrasquillo Jorge,Konner Jason A.,Old Lloyd J.,Larson Steven M.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference22 articles.

1. Cell surface antigens of human trophoblast and choriocarcinoma defined by monoclonal antibodies;Rettig;Int J Cancer,1985

2. The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander?;Kelemen;Int J Cancer,2006

3. Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects;Lu;J Control Release,2003

4. Cellular and humoral responses after multiple injections of unconjugated chimeric monoclonal antibody MOv18 in ovarian cancer patients: a pilot study;van Zanten-Przybysz;J Cancer Res Clin Oncol,2002

5. Experimental and clinical analysis of the characteristics of a chimeric monoclonal antibody, MOv18, reactive with an ovarian cancer-associated antigen;Molthoff;J Nucl Med,1992

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination with folate receptor-alpha peptides in patients with ovarian cancer following response to platinum-based therapy: A randomized, multicenter clinical trial;Gynecologic Oncology;2024-10

2. Active Targeted Nanoformulations via Folate Receptors: State of the Art and Future Perspectives;Pharmaceutics;2021-12-22

3. Novel Anti-FOLR1 Antibody–Drug Conjugate MORAb-202 in Breast Cancer and Non-Small Cell Lung Cancer Cells;Antibodies;2021-02-01

4. Evaluation of therapeutic efficacy of 211At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian cancer;Translational Oncology;2021-01

5. New insight and future perspective of mesothelin-targeted agents in nuclear medicine;Clinical and Translational Imaging;2020-07-23